• +1-646-491-9876
    • +91-20-67278686

    Search

    Erectile Dysfunction Pipeline Review H2 2017

    Erectile Dysfunction Pipeline Review H2 2017

    • Report Code ID: RW0001884134
    • Category Pharmaceuticals
    • No. of Pages 112
    • Publication Month Jul-17
    • Publisher Name Global Markets Direct
    Erectile Dysfunction - Pipeline Review, H2 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape.

    Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants, antihistamines and medications to treat high blood pressure, pain or prostate cancer.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Erectile Dysfunction (Male Health) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 2, 4, 5, 3, 2, 13, 3 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

    Erectile Dysfunction (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Erectile Dysfunction (Male Health) .
    - The pipeline guide reviews pipeline therapeutics for Erectile Dysfunction (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Erectile Dysfunction (Male Health) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Erectile Dysfunction (Male Health) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Erectile Dysfunction (Male Health)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Erectile Dysfunction (Male Health) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Erectile Dysfunction (Male Health) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents 2
    List of Tables 5
    List of Figures 6
    Introduction 7
    Publisher Report Coverage 7
    Erectile Dysfunction - Overview 8
    Erectile Dysfunction - Therapeutics Development 9
    Pipeline Overview 9
    Pipeline by Companies 10
    Pipeline by Universities/Institutes 13
    Products under Development by Companies 14
    Products under Development by Universities/Institutes 16
    Erectile Dysfunction - Therapeutics Assessment 17
    Assessment by Target 17
    Assessment by Mechanism of Action 19
    Assessment by Route of Administration 21
    Assessment by Molecule Type 23
    Erectile Dysfunction - Companies Involved in Therapeutics Development 25
    Apricus Biosciences Inc 25
    Astellas Pharma Inc 25
    Biolab Farmaceutica Ltda 26
    Biopharm GmbH 26
    Can-Fite BioPharma Ltd 27
    Fabre-Kramer Pharmaceuticals Inc 27
    Futura Medical Plc 28
    Hanmi Pharmaceuticals Co Ltd 28
    Humanetics Corp 29
    IntelGenx Corp 29
    Ion Channel Innovations LLC 30
    iX Biopharma Ltd 30
    Mezzion Pharma Co Ltd 31
    Mitsubishi Tanabe Pharma Corp 31
    Monosol Rx LLC 32
    N4 Pharma Plc 32
    NAL Pharmaceuticals Ltd 33
    Nanoform Cardiovascular Therapeutics Ltd 33
    Palatin Technologies Inc 34
    Pharmicell Co Ltd 34
    SK Chemicals Co Ltd 35
    Suda Ltd 35
    XuanZhu Pharma Co Ltd 36
    Yangtze River Pharmaceutical Group 36
    Yungjin Pharm Co Ltd 37
    Erectile Dysfunction - Drug Profiles 38
    alprostadil - Drug Profile 38
    AP-185 - Drug Profile 45
    avanafil - Drug Profile 46
    BIO-300 - Drug Profile 48
    BL-214 - Drug Profile 51
    Cellgram-ED - Drug Profile 52
    CF-602 - Drug Profile 53
    fadanafil - Drug Profile 55
    FKK-01PD - Drug Profile 56
    HCP-1302 - Drug Profile 57
    IPED-2015 - Drug Profile 58
    MED-2002 - Drug Profile 59
    MED-2005 - Drug Profile 62
    mirabegron ER - Drug Profile 63
    moxisylyte - Drug Profile 67
    Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Male Health - Drug Profile 68
    pVAX-hSlo - Drug Profile 70
    Recombinant Protein for Bone Fracture, Degenerative Disc Disease, Erectile Dysfunction and Parkinson's Disease - Drug Profile 72
    sildenafil - Drug Profile 74
    sildenafil citrate - Drug Profile 75
    sildenafil citrate - Drug Profile 76
    sildenafil citrate - Drug Profile 77
    sildenafil citrate - Drug Profile 78
    Small Molecule to Inhibit PDE5 for Erectile Dysfunction - Drug Profile 79
    SUD-003 - Drug Profile 80
    Synthetic Peptide to Agonize Melanocortin 4 Receptor for Female Sexual Dysfunction and Erectile Dysfunction - Drug Profile 82
    T-6932 - Drug Profile 83
    tadalafil - Drug Profile 84
    tadalafil - Drug Profile 86
    tadalafil - Drug Profile 87
    tadalafil - Drug Profile 88
    tadalafil - Drug Profile 89
    TF-0092 - Drug Profile 90
    TPN-729 - Drug Profile 91
    TR-399 - Drug Profile 92
    udenafil - Drug Profile 93
    YBH-1603 - Drug Profile 97
    Yonkenafil - Drug Profile 98
    Erectile Dysfunction - Dormant Projects 99
    Erectile Dysfunction - Discontinued Products 101
    Erectile Dysfunction - Product Development Milestones 102
    Featured News & Press Releases 102
    Appendix 109
    Methodology 109
    Coverage 109
    Secondary Research 109
    Primary Research 109
    Expert Panel Validation 109
    Contact Us 109
    Disclaimer 110

    List of Tables

    Number of Products under Development for Erectile Dysfunction, H2 2017
    Number of Products under Development by Companies, H2 2017
    Number of Products under Development by Companies, H2 2017 (Contd..1) , H2 2017
    Number of Products under Development by Universities/Institutes, H2 2017
    Products under Development by Companies, H2 2017
    Products under Development by Companies, H2 2017 (Contd..1) , H2 2017
    Products under Development by Universities/Institutes, H2 2017
    Number of Products by Stage and Target, H2 2017
    Number of Products by Stage and Mechanism of Action, H2 2017
    Number of Products by Stage and Route of Administration, H2 2017
    Number of Products by Stage and Molecule Type, H2 2017
    Erectile Dysfunction - Pipeline by Apricus Biosciences Inc, H2 2017
    Erectile Dysfunction - Pipeline by Astellas Pharma Inc, H2 2017
    Erectile Dysfunction - Pipeline by Biolab Farmaceutica Ltda, H2 2017
    Erectile Dysfunction - Pipeline by Biopharm GmbH, H2 2017
    Erectile Dysfunction - Pipeline by Can-Fite BioPharma Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Fabre-Kramer Pharmaceuticals Inc, H2 2017
    Erectile Dysfunction - Pipeline by Futura Medical Plc, H2 2017
    Erectile Dysfunction - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Humanetics Corp, H2 2017
    Erectile Dysfunction - Pipeline by IntelGenx Corp, H2 2017
    Erectile Dysfunction - Pipeline by Ion Channel Innovations LLC, H2 2017
    Erectile Dysfunction - Pipeline by iX Biopharma Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Mezzion Pharma Co Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017
    Erectile Dysfunction - Pipeline by Monosol Rx LLC, H2 2017
    Erectile Dysfunction - Pipeline by N4 Pharma Plc, H2 2017
    Erectile Dysfunction - Pipeline by NAL Pharmaceuticals Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Nanoform Cardiovascular Therapeutics Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Palatin Technologies Inc, H2 2017
    Erectile Dysfunction - Pipeline by Pharmicell Co Ltd, H2 2017
    Erectile Dysfunction - Pipeline by SK Chemicals Co Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Suda Ltd, H2 2017
    Erectile Dysfunction - Pipeline by XuanZhu Pharma Co Ltd, H2 2017
    Erectile Dysfunction - Pipeline by Yangtze River Pharmaceutical Group, H2 2017
    Erectile Dysfunction - Pipeline by Yungjin Pharm Co Ltd, H2 2017
    Erectile Dysfunction - Dormant Projects, H2 2017
    Erectile Dysfunction - Dormant Projects, H2 2017 (Contd..1) , H2 2017
    Erectile Dysfunction - Discontinued Products, H2 2017

    List of Figures

    Number of Products under Development for Erectile Dysfunction, H2 2017
    Number of Products under Development by Companies, H2 2017
    Number of Products under Development by Universities/Institutes, H2 2017
    Number of Products by Top 10 Targets, H2 2017
    Number of Products by Stage and Top 10 Targets, H2 2017
    Number of Products by Top 10 Mechanism of Actions, H2 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
    Number of Products by Routes of Administration, H2 2017
    Number of Products by Stage and Routes of Administration, H2 2017
    Number of Products by Molecule Types, H2 2017
    Number of Products by Stage and Molecule Types, H2 2017
    Apricus Biosciences Inc
    Astellas Pharma Inc
    Biolab Farmaceutica Ltda
    Biopharm GmbH
    Can-Fite BioPharma Ltd
    Fabre-Kramer Pharmaceuticals Inc
    Futura Medical Plc
    Hanmi Pharmaceuticals Co Ltd
    Humanetics Corp
    IntelGenx Corp
    Ion Channel Innovations LLC
    iX Biopharma Ltd
    Mezzion Pharma Co Ltd
    Mitsubishi Tanabe Pharma Corp
    Monosol Rx LLC
    N4 Pharma Plc
    NAL Pharmaceuticals Ltd
    Nanoform Cardiovascular Therapeutics Ltd
    Palatin Technologies Inc
    Pharmicell Co Ltd
    SK Chemicals Co Ltd
    Suda Ltd
    XuanZhu Pharma Co Ltd
    Yangtze River Pharmaceutical Group
    Yungjin Pharm Co Ltd

    Request for Sample

    Report Url https://www.reportsweb.com//erectile-dysfunction-pipeline-review-h2-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//erectile-dysfunction-pipeline-review-h2-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//erectile-dysfunction-pipeline-review-h2-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments